Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy
1.13
Ana Teresa Paquete,
Luis Silva Miguel,
Ursula Becker,
Catarina Pereira,
Carlos Gouveia Pinto
Applied Health Economics And Health Policy,
vol. 15, 2017, p. 501-512.